Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 10 November 2025, has recommended a First Interim Dividend of Rs.0.50 per share (i.e.5%), subject to the approval of the shareholders.Powered by Capital Market - Live News

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 November 2025.Powered by Capital Market - Live News

Remus Pharmaceuticals announced that the 10th Annual General Meeting(AGM) of the company will be held on 25 September 2025.Powered by Capital Market - Live News

Remus Pharmaceuticals announced that the 15th Annual General Meeting(AGM) of the company will be held on 24 September 2025.Powered by Capital Market - Live News

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 25 September 2025.Powered by Capital Market - Live News